Evaluation of serum vitamin B12 levels in patients with COVID-19 infection: A case-control study

Evaluation of serum vitamin B12 in patients with COVID-19

  • Yılmaz Sezgin Clinic of Family Medicine, İstanbul Training and Research Hospital, University of Health Sciences Turkey, İstanbul
Keywords: COVID-19, Vitamin B12 deficiency, Homocysteine

Abstract


Background: COVID-19 disease affects the respiratory and cardiovascular systems. Vitamin B12 has been associated with A1AT, one of the protective factors of lung tissue, and homocysteine among the cardiovascular risk factors. Therefore we suggest that low vitamin B12 levels are associated with a disposition to COVID-19 infection. This study aims to determine whether there is a relationship between COVID-19 infection and serum vitamin B12 levels. 

Methods: This research is a case-control study. Seventy-six people with COVID-19 constituted the case group. Seventy-six people without COVID-19 formed the control group. Vitamin B12 and homocysteine levels of 152 patients included in the study were analyzed. 

Results: The odds ratio for vitamin B12 was 0.99 (0.978-0.995). When the value of the vitamin B12 variable decreases by one unit, the risk of COVID-19 increases by 1%. The odds ratio for homocysteine was 1.81 (1.414-2.325). When the value of the homocysteine variable increases by one unit, the risk of COVID-19 increases by 1.81 times. According to ROC analysis, when serum vitamin B12 is below 222.5 ng/L and homocysteine is above 13.7 umol/L, it may increase the risk of COVID-19. 

Conclusions: We suggest that patients with low vitamin B12 levels and high homocysteine levels are more severely affected by COVID-19 infection.

References

1. Dali-Youcef N, Andres E. An update on cobalamin deficiency in adults. QJM 2009; 102(1):17-28.


2. Allen LH. How common is vitamin B12 deficiency. Am J Clin Nutr 2009; 89:693–6.


3. Oh RC, Brown DL. Vitamin B12 deficiency. Am Fam Physician 2003; 67(5):979–86.


4. Allen LH. Vitamin B-12. Adv Nutr 2012; 3(1):54–5.


5. Takemoto C, Spremulli LL, Benkowski LA, et al. Unconventional decoding of the AUA codon as methionine by mitochondrial tRNAMet with the anticodon f5CAU as revealed with a mitochondrial in vitro translation system. Nucleic Acids Res 2009; 37(5):1616–27.


6. Parkhitko AA, Jouandin P, Mohr SE, et al. Methionine metabolism and methyltransferases in the regulation of aging and lifespan extension across species. Aging Cell 2019; 18(6):13034.


7. Levine RL, Moskovitz J, Stadtman ER. Oxidation of methionine in proteins: roles in antioxidant defense and cellular regulation. IUBMB Life 2000; 50(4-5):301–07. 


8. Wu X, Zhang L, Miao Y, et al. Homocysteine causes vascular endothelial dysfunction by disrupting endoplasmic reticulum redox homeostasis. Redox Biol 2019; 20:46–59.


9. Wang L, Niu H, Zhang J. Homocysteine induces mitochondrial dysfunction and oxidative stress in myocardial ischemia/reperfusion injury through stimulating ROS production and the ERK1/2 signaling pathway. Exp Ther Med 2020; 20(2):938–44.


10. Couturaud F, Oger E, Abalain JH, et al. Methylenetetrahydrofolate reductase C677T genotype and venous thromboembolic disease. Respiration 2000; 67(6):657–61.


11. Brosnahan SB, Jonkman AH, Kugler MC, et al. COVID-19 and Respiratory System Disorders: Current Knowledge, Future Clinical and Translational Research Questions. Arterioscler Thromb Vasc Biol 2020; 40(11):2586–97.


12. Azevedo RB, Botelho BG, Hollanda JVG, et al. Covid-19 and the cardiovascular system: a comprehensive review. J Hum Hypertens 2021; 35(1):4–11.


13. Guzik TJ, Mohiddin SA, Dimarco A, et al. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc Res 2020; 116(10):1666–87.  


14. Senn O,  Russi EW, Imboden M, et al. α1-Antitrypsin deficiency and lung disease: risk modification by occupational and environmental inhalants. European Respiratory Journal Nov 2005; 26(5):909–17. 


15. Sezgin Y, Kartal M, Güldal AD. A comparison of serum alpha-1-antitrypsin and vitamin B12 levels in patients with vitamin B12 deficiency. J Clin Anal Med 2018; 9(3):192–4. 


16. Shenov V, Mehendale V, Prabhu K, et al. Correlation of serum homocysteine levels with the severity of coronary artery disease. Ind J Clin Biochem 2014; 29(3): 339–44. 


17. Veeranna V, Zalawadiya SK, Niraj A, et al. Homocysteine and reclassification of cardiovascular disease risk. J Am Coll Cardiol 2011; 58:1025–33.


18. Sezgin Y. Approach to Vitamin B12 Deficiency. Konuralp Med J 2019; 11(3):482–8. 


19. Dharmarajan TS, Adiga GU, Norkus EP. Vitamin B12 deficiency. Recognizing subtle symptoms in older adults. Geriatrics 2003; 58(3):30–38. 


20. Chang WH. Understanding the COVID-19 pandemic from a gender perspective. Taiwan J Obstet Gynecol 2020; 59(6):801–7.


21. Bwire GM. Coronavirus: Why Men are More Vulnerable to Covid-19 Than Women? SN Compr Clin Med 2020;2(7):874–6.


22. Vianello A, Braccioni F. Geographical Overlap Between Alpha-1 Antitrypsin Deficiency and COVID-19 Infection in Italy: Casual or Causal? Arch Bronconeumol 2020; 56(9):609–10.


23. Ede G, Ayaz A. The Effect of Vitamin B12 and folic acid on adiposity. Bes Diy Derg 2016: 44(1):47–54.


24. Nappo F, De Rosa N, Marfella R. Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins. JAMA 1999; 281:2113–8.  

Published
2023/05/06
Section
Original paper